CVRx, Inc.
NASDAQ:CVRXMedical - Devices
+$0.11 today
- Market cap
- $69.79M
- Beta
- 0.77
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$2.00
Volume 0.37M
Average 0.30M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
CVRx, Inc.
NASDAQ:CVRX
Intrinsic Alpha fair value
Locked
Current Price
$2.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +36.1% | +16.8% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +36.1% over three years. Forward estimates point to Revenue at +16.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Cerus Corporation NASDAQ:CERS | $528.00M | $2.62 | Overvalued | -53.8 | +27.52% |
Sight Sciences, Inc. NASDAQ:SGHT | $485.88M | $8.93 | Not rated | -7.5 | +59.94% |
908 Devices Inc. NASDAQ:MASS | $469.35M | $11.44 | Not rated | -9.0 | +64.39% |
Senseonics Holdings, Inc. NASDAQ:SENS | $417.94M | $10.00 | Not rated | -3.5 | +68.98% |
Viemed Healthcare, Inc. NASDAQ:VMD | $339.37M | $8.91 | Undervalued | 27.4 | +35.59% |
ProQR Therapeutics N.V. NASDAQ:PRQR | $173.76M | $1.65 | Not rated | -3.8 | -49.03% |
Quanterix Corporation NASDAQ:QTRX | $154.04M | $3.27 | Not rated | -1.5 | -65.65% |
Nano-X Imaging Ltd. NASDAQ:NNOX | $44.56M | $0.64 | Not rated | -1.5 | -78.79% |
SANUWAVE Health, Inc. NASDAQ:SNWV | $43.34M | $5.04 | Undervalued | 5.0 | -81.50% |
Continue the stock analysis
Jump to another research area for this company.